Back to Career News

MSN Labs launched cheapest COVID-19 medicine

August 14, 2020

MSN Labs launched cheapest COVID-19 medicine

MSN Group introduced the rollout of the most inexpensive Covid-19 treatment drug Favipiravir 200 mg at ₹33 in step with pill beneath the Favilow logo.

Jenburkt Pharmaceuticals’ Favivent become hitherto the cheapest Favipiravir 200mg providing in the market at ₹39 in line with pill. While Glenmark’s Favipriavir offering Fabiflu was released at ₹103 in step with the pill and later reduced to ₹75 consistent with pill, Cipla’s Ciplenza charges ₹68, Hetero Labs’ Favivir and Brinton Pharma’s Faviton are priced at ₹59.

The Hyderabad-based employer said it’s also gearing up to release Favipiravir 400mg inside the market quickly. The active pharmaceutical aspect (API) and the formulation for Favilow were evolved in-house via its R&D crew.

MSN Group CMD Dr MSN Reddy said, “We as an organization always accept as true with that first-class medicinal drug must be available and available to everyone”.

Recommended for you ...

India likely to be fastest growing economy
India likely to be fastest growing economy

August 12, 2022

Building a strategic procurement function in retail banking
Building a strategic procurement function in retail banking

August 12, 2022

ICICI Bank hits ₹6 trillion m-cap the first time
ICICI Bank hits ₹6 trillion m-cap the first time

August 12, 2022

Chat on WhatsApp